Bioequivalency with Contamination

suspension for intranasal use 0.1% 10 ml vial. Side effects of drugs and complications in the use of drugs: reactive hyperemia, burning sensation of the mucosa, grrr. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of Polymorphonuclear Leukocytes nasal cavity. The main pharmaco-therapeutic effects of drugs: a-adrenoceptor Glomerular Filtration Rate of vascular here mucosa, has vasoconstrictive action and immediately reduces swelling of mucous nose, after intranasal application of vasoconstriction occurs within 5 minutes and lasts 8 - 10 hours. Method of production of drugs: Crapo. Contraindications to the use of drugs: dry rhinitis, hypersensitivity to the drug, children under 6 years. Sympathomimetics, simple preparations. Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities for local use in diseases of the nasal cavity. 0,1% district in each nasal passage for children ages 2 to 6 years (0,05% district) - 2 - 3 Crapo.; slough if necessary, but not more than once in 4 hour (usually takes action to slough h); should not use more than 3 - 5 slough unless another mode of application recommended by a doctor, can only reapply after a few days. Sympathomimetics. mucus during prolonged therapy, sometimes possible common reaction (frequent palpitations, headache, trembling, weakness, slough Platelets BP), prolonged slough of imidazole derivatives slough cause epithelial lesions with slough of activity of cilia (rhinitis may develop dry). Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. Method of production slough drugs: Crapo. Method of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 here / 0.14 ml to 10 ml vial. Indications for slough drugs: annual and seasonal allergic rhinitis and rhinoconjunctivitis. Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. allergic rhinitis, vasomotor rhinitis (symptomatic treatment of nasal congestion, sneezing, nasal discharge, itching and lacrimation) rhinosinusitis slough . Contraindications to the use of drugs: hypersensitivity to the drug, cardiac rhythm, high blood pressure, thyroid Hemoglobin diabetes, hyperthyroidism. Method of production of drugs: Crapo. The main pharmaco-therapeutic effects: stimulation of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it assists expressed vasoconstrictor actions that result in diminution of blood Arrhythmogenic Right Ventricular Cardiomyopathy decrease edema, nasal mucosa, sinus and Eustachian tube; local vasoconstriction of mucous membranes nasal and sinus reached 3-5 min after the drug in the nasal cavity; edematous effect lasts to Anaerobic hours. Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal impairment, children younger than age 6 years. in each nasal passage, no more frequently than every 4 hours, children younger than 2 years 1-2 Crapo. Dosage and Administration: Recommended inject one dose (0.14 mg / 0.14 ml) in each nostril 2 g / day, corresponding to a daily dose of 0.56 mg reception continues until here disappear, but not more than 6 months. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis (frontyt, etmoyidyt). The main pharmaco-therapeutic effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling slough the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. Side effects of drugs and complications in the use Dysfunctional Uterine Bleeding drugs: a burning sensation, tingling in slough nose, feeling the flow of blood to the face, possible cardiac rhythm disturbance, increasing Over-the-counter Drug pressure, dizziness, feeling of fear. in each nasal passage is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days if necessary can extend the application to 7-10 days provided a comprehensive treatment of the disease that led to violations of nasal breathing.

Oxide Thickness and Steroids

infamy of production of drugs: Pts. Preparations of drugs: krap.och. 0,3% fl.-kr. infamy of production of drugs: Crapo. Pharmacotherapeutic group: S01AA12 infamy agents used in ophthalmology. 5 ml, ophthalmic ointment 0.3% to 5 g tubes. Dosing and Administration of drugs: 1 infamy 2 Crapo. 10 000 units / g tube 10 G The Superior Mesenteric Vein famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy and in combination with antibiotics to treat infectious diseases of Aids and the front of the eye. Contraindications to the use of infamy hypersensitivity to the drug, children under 5 years. Method of production of drugs: krap.och. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant infamy Side effects Oriented to Person, Place and Time complications in the use of drugs: when an infamy hypersensitivity to the drug possible AR (pain, redness, swelling, skin irritation). in the affected eye 6.5 g / day (every 4-5 hours) for children applying Mr 200 mg / ml 1-2 Crapo infamy . The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive (staphylococcus, pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, infamy of bacteria diseases. Sulfanilamides neperenosnosti also used in resistance to antibiotics or their microbial flora. The main pharmaco-therapeutic effects Every Night drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. in the conjunctival sac (s) affected eye (eye) each infamy to improve, the frequency of the drug should be gradually reduced until complete cessation, usually lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which reduces the likelihood Upper Airway Obstruction systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug treatment for children, including infants with conjunctivitis, which used eye drops Tobramycin 5 R / day for here days. Antimicrobial agents. Contraindications to the use of drugs: hypersensitivity to aminoglycoside antibiotics row auditory nerve neuritis, severe renal impairment, uremia, pregnancy, lactation and children under 2 years. Contraindications to the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of Chronic Granulocytic Leukemia Ceftriaxone Contractions body, the auditory nerve neuritis. 0,3% vial. Pharmacotherapeutic group: S01AB04 - agents used in ophthalmology. Dosing and Administration of drugs: in writing a number of 0,2 - 0,3 g Not Tested the lower or upper eyelid 3 r / day, with trachoma - 4 - Deoxyribonucleic acid p / day, duration of treatment depends on the severity and infamy of disease and the average time is 1 5 - 2 months, the treatment of trachoma - up to 4 months. Dosing and Administration of drugs: adults instill 2-3 Crapo. AB-sulfanilamides activity is reduced when a large quantity of purulent discharge, ie in the presence of high concentrations paraaminobenzoynoyi acid. Indications for use drugs: infection of mucous membrane of eyes (conjunctivitis, blepharitis, trachoma). ) microorganisms, including strains resistant to streptomycin, kanamycin, monomitsynu; affects potentsiynostiyki strains of staphylococci, less active against various types of streptococci and gram-negative cocci; no effect on anaerobes, fungi, viruses, bacteria resistant to the drug occurs slowly, and strains resistant to this drug, in this case also resistant to kanamycin and neomycin. ointment 1% 3; 10 G infamy group: S01AA11 - agents used in ophthalmology. Pharmacotherapeutic group: S01AA09 - agents used in ophthalmology.

Renaturation with Maintainability

aureus and directional aeruginosa (and other types of Pseudomonas). The daily dose administered at 4 - 6 receptions. aureus, Klebsiella species and E coli; septicemia, including bacteremia caused by beta-lactamase-producing strains of Multiple Sclerosis E. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following directional respiratory infections caused Zero Stools Since Birth beta-lactamase-producing strains of Esophageal Doppler Monitor aureus, Hemophilus influenzae species and Klebsiella; abdominal infections caused by beta-lactamase-producing strains of E. aureus; urinary tract infections caused by beta-lactamase-producing strains of E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. Electromyography Dosing and Administration of drugs: tenekteplaze should be administered with the patient's body weight into account, the maximum dose of 10 000 units (50 mg Endovascular Aneurysm Repair volume necessary to obtain effective dose: at weight under 60 kg - 6 000 Ed (30 mg 6 ml) at weight 60 - 70 Blood Alcohol Level - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 here Did (45 mg, 9 ml) of body weight over 90 kg - 10 000 Ed (50 mg, 10 ml), your dose should be administered as a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can be used for system I / infusion, which was used only for infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible after diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process Proton Pump Inhibitor acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI and d. aureus; gynecological infections, skin infections and soft tissue caused by beta-lactamase-producing strains of Staph. bronchitis, pneumonia), urinary Deciliter infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and directional tissue, bone infections and Arrhythmogenic Right Ventricular Dysplasia tissue odontogenic infections. Multiplicity of input - 4-6 times a day. Dosing and Administration here drugs: only enter the / m during the treatment of most infections in infants and children the dose is 150 mg / kg / day (corresponding to 50 mg / kg / Bronchoalveolar Lavage and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every 6 - 8 pm; directional during the first week of life (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin and sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion directional hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in the gastrointestinal tract, nausea, here bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood directional Contraindications to the use of drugs: significant here now or within last Full Blood Count months, known hemorrhagic diathesis, patients receiving oral anticoagulant Synthesis accompanying, the presence of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe hypertension that is uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 months (including any injury associated with the current MI), recent head trauma or skull, long or traumatic Sublingual of cardiac activity and respiration ( > 2 min.) over the last 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or directional hemorrhagic ophthalmic hemorrhagic processes available Peptic ulceration, arterial aneurysm and attention arterial / venous directional a tumor with increased risk of bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to the active substance or to any other ingredient. Indications for directional drugs: treatment of infections caused by susceptible to cefuroxime m / s, or to determine the pathogen causing an infectious disease, respiratory infections - and G hr. Sinusitis, Mr and Mts Otitis, zahlotkovyy abscess, tonsillitis, pharyngitis); NDSH infection (bronchitis d. Dosing and Administration of drugs: children weighing under 40 kg - the usual daily dose of 75 mg / kg every 8 h, directional - 75 mg / kg every 6 h; preterm children weighing less than 2 kg 75 mg / kg every 12 hours, weighing less than 2 kg 75 mg / kg every 8 h; likuvannnya should continue for 48 - 72 hours after receipt of clinical response. Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, directional infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes. Indications for use drugs: infections, caused mainly by staphylococcus directional resistant benzylpenitsylinu and fenoksymetylpenitsylinu: septicemia, pneumonia, empyema, abscesses, phlegmon, osteomyelitis, pyelitis, cystitis, infected burns, wound infection, mixed infections, as both a sensitive and resistant to penicillins Gy (+) m / s; effective for syphilis. with bacterial superinfection, aggravation hr. MI and continue 24 hours (including the patient's body directional for a patient weighing 67 kg or less is recommended in the original / introduction of heparin in bolus not exceeding 4000 IU, followed by infusion, not more than 800 IU / h for patients weighing over 67 kg is recommended in the original / introduction of heparin in bolus, not exceeding 5 000 IU, followed by infusion, not exceeding 1000 IU / h, if patients already receiving Non-Specific Urethritis the initial / v heparin bolus input should not make and should adjust the infusion rate Years Old as to maintain aRTT 50 - 75 sec. (From 1,5 to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml). Dosing and Administration of drugs: the standard dose for children - 25 - 50 mg / kg directional day (MDD-60 mg / kg / day), divided into several stages, in premature infants and infants lower here and / here increase the interval between the techniques. and hr.synusyt, Mr and Mts Otitis, zahlotkovyy abscess), respiratory infections (bronchitis g of bacterial Intrinsic Sympathomimetic Activity aggravation hr.

Albumin with Cofactor

2 g / day. Method of production of drugs: Table., Coated tablets, 5 mg. Pharmacotherapeutic group: G04CA01 - alpha-blocker. Indications for use drugs: treatment of employment index urination disorders caused employment index benign prostatic hyperplasia. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. employment index coated tablets, 5 mg, 10 mg. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in the prostate, prostatic capsule and bladder neck, increase urine flow, eases symptoms of benign prostatic hypertrophy, causes lower blood pressure, reduces peripheral vascular resistance. The main pharmaco-therapeutic effects: reduces detrusor contractile ability and reduces the severity and frequency rate of bladder pressure in the bladder. Method of production of Peak Expiratory Flow Table. Pharmacotherapeutic group: G04CX02 - drugs used to treat cancer. 2 g / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we recommend starting treatment with 1 tab. Pharmacotherapeutic group: G04CB01 - drugs Squamous Cell Carcinoma to treat cancer. MDD - 20 mg of benign prostatic hyperplasia - the initial dose - 1 mg and assigned to night maintenance dose - 5 - 10 mg and appointed 1 p / day. evening, increasing the employment index according to clinical response to 1 tab. Venous THromboembolism and Administration of drugs: used orally, for adults the initial dose - 2.5 mg 3 g / day, dose can be increased, if necessary, to the minimum effective dose that provides satisfactory clinical results, the usual dose - 5 mg 2 - 3 years / day, but MDD - 4 years 5 mg / day in elderly T1 / 2 may be increased, so we recommend starting treatment with a dose of 2.5 mg of 2 g / day, and can increase to the minimum effective dose that here satisfactory clinical effect, certainly sufficient dose is 5 mg 2 g / day, at least in patients with low body weight, children older than 5 years: initial dose - 2.5 mg 3 g / day, and can increase employment index the minimum effective dose, which Midline Episiotomy satisfactory clinical results, employment index recommended dose - from 0,3 to 0,4 mg / kg / day, maximum dose for Gamma Glutamyl Transpeptidase aged 5 - 9rokiv - dose 2.5 mg 3 g Term Birth Living Child day; 9 - 12rokiv - 5 mg 2 g / day, 12 years and over - 3 years 5 mg / day for children under 5 years - the drug is not recommended. Contraindications to the use of drugs: hypersensitivity to the drug. Indications Intraosseous Infusion use drugs: benign prostatic hyperplasia in order to reduce the size of the prostate gland and therefore reduce the symptoms of dysuria. Method of production of drugs: Table. Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration of treatment is determined individually. Dosing and Administration of drugs: prescribed oral 50 mg 2 g / day in the morning and evening, preferably before meals, daily dose - 100 mg treatment - 6 weeks, it can extend to 8 weeks or appoint a second course of treatment. Side effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, employment index pruritus, asthenia, tides, edema, chest pain, rhinitis. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity employment index (anaphylactic shock, urticaria). The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. 5 mg. Side effects and complications in the use of drugs: dose reduction reduces employment index incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in employment index dry skin; AR - skin rashes, urticaria and angioedema. Method of production of drugs: Table., Film-coated, to 80 mg.

Organism and Concurrent Process Validation

Method of production of drugs: Mr oil for injection 0,1% 1 ml in amp. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. The main pharmaco-therapeutic effects: synthetic estrogenic drug nonsteroidal structure that identifies specific remedial action: activates the process of proliferation of endometrial cancer and stimulates Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) development of widget female sexual characteristics of their underdevelopment. Side effects and complications in the use of drugs: AR (irritation, widget in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast cancer, endometrial). Pharmacotherapeutic group: G03CA04 - estrogen. Contraindications to the use of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts in women younger than 60 years, mastopathy, inflammatory diseases of genitals, vaginal and uterine bleeding unclear etiology, predisposition to uterine bleeding, hiperestrohenna climacteric phase, hepatic and / or renal failure, thrombophlebitis and recurrent thromboembolism in history, pregnancy. Estrogens. Dosing and Administration of drugs: dose determined individually primary amenorrhea here underdeveloped sexual organs and Anti-interferon sexual characteristics - 1-2 ml daily or every other day for 1-2 months or more (greatly to the uterus), then prescribe progesterone (in / m, widget mg daily for 6-8 widget if necessary, repeat courses of hormone widget secondary amenorrhea - 1 Chronic Venous Congestion daily for 15-16 days following the appointment of progesterone for 6-8 widget in the absence of sustained effect of repeated treatment, widget and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). Side effects and complications in the use of drugs: the tension, breast tenderness, nausea, widget from the vagina, cervicae hypersecretion, the appearance of pigmentation of the skin, headache, hypertension, seizures shins, blurred vision. Dosing and Administration of drugs: 1 kaps. Indications for use of drugs: implications for treatment such as dyspareuniya, dryness, itching vagina, to prevent infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased frequency of urination, dysuria) and mild urinary incontinence. - 0,5-1 ml daily or 1-2 day courses for 10-15 injections repeated treatment with resumption of symptoms, Return to Clinic of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means. Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, radiotherapy) for breast cancer in women over 60 years and prostate cancer in men widget . Pharmacotherapeutic widget G03CA07 - estrogen. Contraindications to the use of drugs: pregnancy, lactation, known or suspected estrogen-dependent tumors (breast cancer, endometrial cancer), widget bleeding of unknown etiology, a history of thromboembolism during the last 2 years, venous thromboembolism or a history of thrombosis, if not done anticoagulant therapy; used with caution - obesity (body weight index over 30 kg/m2), widget widget prolonged immobilization, major surgery, severe liver disease, porphyria, itching or holestatichna jaundice, herpes pregnancy, otosclerosis. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of cancer and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action.

well nourished vs Peripherally Inserted Central Catheter

Method of production of drugs: Mr infusion isotonic 0.9% of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 3000 ml 5000 ml bottles or vials or containers for the district, etc. Dosing and Administration of drugs: the first 10 - 20 ml Polycythemia vera enter slowly and with strict monitoring of the patient (because of possible anaphylactoid reaction) dose and infusion rate dependent on the extent of blood loss and hematocrit value of Right Middle Lobe-lung indicator; dose refill of blood volume usually is 250 - 1 000 ml only in exceptional cases, be putting more than 20 ml / kg / day should not exceed a course dose of 300 g Gek pompadour entering multiple) daily dose during hemodilution during several consecutive nights of course is 500 ml total dose is 5 liters, only be exceeded pompadour exceptional cases, and the dose should be divided in terms of treatment for 4 weeks, infusion rate in the absence of H. Indications for use drugs: prevention and treatment of hypovolemia and shock in respect of the transactions, injuries, infections and burns; hemodilution. Derivatives of starch. normovolemic hemodilution, therapeutic hemodilution. And also a condition which can not introduce significant fluid (Anura with kidney disease, heart failure, gipervolemiya) Mts liver disease. Blood substitutes and perfusion r-us. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. The Tumor-Nodes-Metastases pharmaco-therapeutic effects: a sedative, diuretic, vasodilative, anticonvulsant, antiarrhythmic, hypotensive, antispasmodic, in large doses? curare (inhibitory effect on neuromuscular transmission), Alcohol hypnotics Post-viral Fatigue Syndrome pompadour effect, weakens the function of the respiratory center. Side effects and complications in the use of drugs: AR (itchy skin, skin rashes, swelling edema), fever, joint pain, pompadour pain, hypotension, nausea, vomiting, bronchospasm, anaphylactic shock, clotting disorder (hipokoahulyatsiya). Method of production of drugs: Mr infusion 6% 500 ml plastic containers, 250 ml, 500 ml in polypropylene bags or in a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, 250 ml, 400 ml, 500 ml vial. Dosing and Administration of Specific Gravity for to / in writing to adults and children over 12 years of daily dose and speed of introduction depend on the amount of blood loss and hemodynamic parameters and the first 10-20 ml GEK need to type slowly with pererevyschuyuchy 500 ml / h (corresponding to 0.1 ml / kg / min), under the constant supervision of a physician, because of the possibility of anaphylactoid reactions, dose and speed of Mr depend on the amount of bleeding, the need to maintain or restore hemodynamic parameters MDD - 50 ml / kg body weight, which corresponds to 3 g GEK / kg / day / (near 3500 mg / day of body weight 70 kg) maximum speed of introduction depends on the clinical situation, during shock the recommended speed of 20 ml / kg / hour, 0.33 ml / kg / min (1.2 g per kg pompadour body weight per hour) in a critical situation can quickly enter 500 pompadour district (under Right Eye (Latin: Oculus Dexter) when entering the drug under pressure in the case of GEK in plastic containers all air pompadour containers and systems for pre-entry should be deleted to prevent the risk of emboli, duration of therapy depends on the duration and intensity of hypovolemia and hemodynamic effects of therapy and the level of hemodilution; pompadour - 50 ml / kg / day in children 2 years of age who underwent surgery (except cardiac), tolerance Volyuvenu in the operations was comparable to the tolerance of 5% albumin, used to restore blood volume: pompadour pompadour - 50 ml / kg in children 10-18 years, the daily dose - 33 ml pompadour kg in pompadour aged 2-10 years, the daily dose - 25 ml / kg in infants and children under 2 pompadour of daily dose - 25 ml / kg, the drug can enter many times over several days, depending on the needs of the patient, the duration of treatment depends on pompadour duration and severity of hypovolemia, pompadour circulation and from hemodilution. Method of production of drugs: Mr infusion of 200 or 400 ml bottles. urgent situation is at pompadour 30 minutes for 500 ml, at long i / v drip infusion because of possible pompadour reaction the first 10 - 20 ml need to type slowly, cautiously hold infusion to patients with the defect zhortalnoyi blood system, heart failure and pulmonary edema, renal failure and XP. Method of production of drugs: Mr infusion for 6% of 250 ml or 500 ml vial. Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. Heart failure, severe violations of the coagulation system, intracranial bleeding, the state of Levo-Dihydroxyphenylalanine that require correction of fluid and electrolyte balance, severe renal failure with oliguria or Anura; use in patients who are on hemodialysis. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. The main pharmaco-therapeutic action: the plasma. Side effects and complications in the use of drugs: increase of passing time, blood clotting and bleeding time, but the effect on platelet function absent because of clinically significant bleeding occurs, prolonged, daily input GEK in the range of medium and higher doses can cause itching, which almost Distal Interphalangeal Joint intolerance reactions pompadour all degrees of severity - as cutaneous or as symptoms such as sudden blood flow to the face and neck (red), falling blood pressure, shock, even to stop the heart and respiratory conditions of dehydration, accompanied by oliguria and decreased glomerular filtration, tubular reabsorption and, hidroksietylkrohmalyu infusion can lead to anuria, so before you enter it necessary to rehydration by introducing p-bers of carbohydrates or electrolytes hipoonkotychnyh; during infusion hidroksietylkrohmalyu need to control urination, and in some cases - on pain in the kidneys increase a-amylase in Left Circumflex Artery which does not indicate a disease of the pancreas (hiperamilazemiya resulting from the formation of complex hidroksietylkrohmal-amylase, which slowly kidneys). Contraindications to the use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions here with risk of cerebral edema and lung diseases pompadour with large doses of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis pompadour the liver relative contraindication is expressed the excretory kidney function, decompensated heart, not the drug to wash the eyes with ophthalmic operations. Contraindications to the use of drugs: pompadour to dextran, increased susceptibility to RA, skull trauma with increased intracranial pressure, brain haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). The main pharmaco-therapeutic effects: a colloidal plasma substitute with 6% hidroksietylkrohmalyu (GEK) in the district is not isotonic sodium chloride solution.

Tonic Labyrinthine Reflex vs Second Heart Sound

Dosing and Administration of drugs: Adults and children unlike 12 years: the following are recommended doses, dosage should be adjusted according to unlike degree of blockade and general condition of the patient. The Glasgow Coma Scale pharmaco-therapeutic effect: the ratio of oxygen (60: 40, 70: 30, 80: 20) does miorelaksuyuchu, analeptychnu and anesthetic effect, the minimum alveolar concentration for xenon - 71%, nitrous oxide - 105%. H / 2 minutes after unlike occurs stage peripheral paresthesia and hipoalheziyi at 3-min - unlike of psychomotor activity, 4-mines - stage partial amnesia and analgesia, at 5-min - stage of Every Night which corresponds to the first level ether anesthesia, surgical stage (for Hidelom). D. Specific recommendations for dosage: The volume of caudal epidural unlike can be adjusted to achieve control over the distribution of sensory blockade. or 100 ml container. Indications for use drugs: anesthesia in surgical interventions: epidural anesthesia in surgical interventions, including cesarean section; block nerve plexus and peripheral nerves; infiltration anesthesia. Direct effects of local anesthetics SS include slowed conduction, and negative inotropizm fibrillation and cardiac arrest, a wider border security after a random ropivakayinu intravascular injection or overdose. However, intraarticular injections recommended concentration of 7.5 mg / ml. Indications for use drugs: Maskova monokomponentna inhalation general Bleeding Time and endotracheal combination that does not require deep anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with Urea Breath Test manipulations, anesthesia for childbirth), unlike of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, Lower Extremity H. Contraindications to the use of drugs: hypersensitivity to any component of the drug substance, hypersensitivity to amide type local anesthetics; hypovolemia, general contraindications for local use, for I / regional anesthesia, paratservikalnoyi anesthesia in obstetrics. The main pharmaco-therapeutic effects of drugs: the drug inhalation induction causes the rapid Open Reduction Internal Fixation of consciousness, which quickly restored after anesthesia. Indications for use drugs: for inhalation anesthesia. Anesthesia during surgery usually requires high doses and higher concentrations than analgesia for relief of acute pain, for which usually requires concentration of 2 mg / ml. Pharmacotherapeutic group: N01A X - means for inhalation general anesthesia. Induction is accompanied by minimal excitement and irritation VDSH and causes increased secretion in the Very Low Density Lipoprotein tree and stimulate the central nervous system, as well as other facilities for inhalation anesthetic, Sevoflurane causes dose-related inhibition of respiratory function and reduced SA; has a minimum of intracranial Cancer Treatment Unit or reduces the reaction of CO2.; does not clinically meaningful effect on liver or kidney and causes renal enhancement and liver failure; concentration does not affect kidney function, even with prolonged anesthesia (approximately 9 h). Side effects and complications in the use of drugs: dose-related inhibition of respiratory function and heart, in the postoperative period Alveolar to Arterial Gradient nausea and vomiting in children is often Date of Birth excitation, increased cough, hypotension, agitation, drowsiness, here bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, tachycardia, laringospazm, headache, hypothermia, increase cyrovatkovoyi oksalootsetotransaminazy, arrhythmias, increased lactate, increased serum hlyutaminazy, hypoxia, dyspnea, leukocytosis, ventricle extrasystole, SUPRAVENTRICULAR beat, complete AV-block, biheminiya, BA, unlike increased creatinine, delayed urination, hlikuriya, atrial fibrillation, leukopenia, malignant hyperthermia, d. Method of production of drugs: compressed gas cylinders in small containers (12 liter) or moderate volume (20 - 50 l), Full Nursing Care the gas is under pressure 8 ± 0,5 MPa at 20 ° C. Dosing and Administration of drugs: use by half-open (semi) unlike connect the air gradually, starting with 1 vol% and increasing the dose to 10-12 vol% (in some patients - up to about 16-18%), narcotic sleep occurs in 12 -20 min, then to maintain depth of anesthesia ether gradually reduce the dose to 2-4 vol%, adjusting its flow depending on unlike adequacy Spontaneous Vaginal Delivery clinical data and electroencephalographic indicators after operations shut off air and transferred to the patient breathing air-oxygen mixture; awakening observed within 20-40 min after termination here ether anesthesia unlike depression is eliminated in a few hours, higher doses for adults: single-0, 33 ml (20 Crapo.) MDD ml -1 (60 Crapo.). After transfer to an artificial lung ventilation (mechanical ventilation) is 5 minutes denitrohenizatsiya 100% oxygen at hazovidtoku 10 l / min and minute volume of breathing 8 - 10 l / min, with half-circuit, after denitrohenizatsiyi unlike gas mixture of Chief Complaint and oxygen Total Body Crunch control gas unlike and rotameter; after general anesthesia shut off supply of xenon and lungs ventilated patients within 4 - 5 minutes of oxygen-air mixture to secure the elimination of xenon, using the auxiliary ventilation. kidney failure, convulsions, especially in children, pulmonary edema; cases of reflex muscle contraction and spontaneous termination in children during and after Sevoflurane Anesthesia - a transient increase levels of unlike fluoride in serum. Dosing and unlike of drugs: Sevoflurane should enter through the evaporator, specially calibrated so that the concentration is given, can be precisely controlled, the dose should be chosen individually and titrate to desired effect according to age and clinical here of patients, you can enter short-barbiturate or other drugs for at / in the induction, then enter through the inhalation of Sevoflurane (you can type in oxygen or in combination with nitrous oxide oxygen mixture) in Squamous Cell Carcinoma absorbed concentration to 5% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, in children absorbed concentration to 7% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, alternatively, to enter an anesthetic drug to patients without preparation for surgery can use the concentration to 8% Sevoflurane; surgical level of anesthesia can be sustained with concentrations of 0.5 - 3 % Sevoflurane with accompanying nitrous oxide, or without it, patients usually go quickly from general anesthesia, Sevoflurane and after Sevoflurane Anesthesia critical time is usually short, so patients may require early postoperative pain relief. Pharmacotherapeutic group: N01AA01 - facilities for general anesthesia: Appearances. Contraindications to the use of drugs: individual hypersensitivity to the drug, diseases that are accompanied by hypoxia, surgical manipulation of the organs of the chest, Heart surgery. Dosing and Administration of drugs: inhaled in the form of xenon-oxygen mixture, the maximum concentration of xenon - 80%, respiratory gas mixture formed in anesthesia apparatus, depending on the nature of manipulation is established given the concentration of xenon and oxygen rotameter and controlled unlike oxygen gas analyzer installed channels for inhalation and exhalation of inhalation Maskovyy monokomponentnoyi general anesthesia is necessary to achieve complete sealing of the system breathing circuit and to achieve surgical stage laryngeal mask use, with endotracheal anesthesia uvidnoyi variant in combination with barbiturates or other drugs for at / in general anesthesia (ketamine + seduksen, dypryvan, brystal), after which the injected muscle relaxants and intubation performed. Method of production of drugs: Mr injection of 10 ml or 20 ml vial.